Independent Drug Co.

Xenomics, Inc., and its Subsidiary TrovaGene, Inc., Announce Italian Patent for NPM1 Testing for AML Patients.
Blood Weekly; 1/7/2010; 1065 words; ...provided by the number of presentations by independent groups working on NPM1 at the 51st Annual...marker for AML. Xenomics has also signed co-exclusive worldwide rights to Ipsogen...for forensic identity determination, drug development, and research to counter...

Recent findings from D.R. Friedman and co-authors highlight research in chronic lymphocytic leukemia.
Blood Weekly; 1/7/2010; 980 words; ...and applied these three signatures to independent clinical data from four cohorts, representing...progression signature was validated in two independent data sets, showing a capacity to accurately...Chemotherapy, Chronic Lymphocytic Leukemia, Drug Therapy, Experimental Design, Genetics...

EquityNet Research Initiates Independent Analyst Coverage of Huifeng Bio-Pharmaceutical Technology.
Biotech Week; 1/6/2010; 712 words; ...of the company as an independent analyst (see also Biopharmaceuticals...future to compensate an independent analyst to perform a...by Charles Schwab & Co., reported in The...value research from independent firms over analysis...Biopharmaceuticals, Drugs, Pharmaceuticals...

Research from Y. Maejima and co-authors reveals new findings on oxytocin therapy.
Biotech Week; 1/6/2010; 639 words; ...signaling in the PVN that triggers leptin-independent melanocortin-mediated anorexia...Nucleus Causes Anorexia through a Leptin-Independent Melanocortin Pathway. Cell Metabolism...Japan, Adolescent Medicine, Anorexia, Drugs, Eating Disorders, Metabolism, Oxytocin...

ARIAD Announces Full Enrollment in Phase 3 Succeed Trial Evaluating Ridaforolimus in Patients with Metastatic Sarcomas.
Cancer Weekly; 1/5/2010; 1664 words; ...arm. In September, the independent Data Monitoring Committee...its partner, Merck & Co., Inc., have a global...collaborating with Merck & Co., Inc. to globally...FDA) and as an orphan drug by the European Medicines...commercialize small-molecule drugs to treat cancer in ...